Ozarelix
id:
ozarelix-284-4071938
title:
Ozarelix
text:
Ozarelix is a peptide gonadotropin-releasing hormone antagonist which is or was under development by AEterna Zentaris Inc. and Spectrum Pharmaceuticals as a long-acting injection formulation for the treatment of prostate cancer. It has also been investigated for the treatment of endometriosis, but no development has been reported. The drug was previously under investigation for the treatment of benign prostatic hyperplasia and Alzheimer's disease as well, but development for these indications wa
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Ozarelix
date created:
date modified:
2023-11-29T05:47:05Z
main entity:
{"identifier":"Q27286888","url":"https://www.wikidata.org/entity/Q27286888"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/e/e4/Ozarelix.svg","width":2004,"height":804}
fields total:
13
integrity:
15